These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 11776707)
41. Current gene-mapping strategies in experimental models of multiple sclerosis. Becanovic K; Jagodic M; Wallström E; Olsson T Scand J Immunol; 2004; 60(1-2):39-51. PubMed ID: 15238072 [TBL] [Abstract][Full Text] [Related]
42. Study of HLA as a predisposing factor and its possible influence on the outcome of multiple sclerosis in the sanitary district of Calatayud, northern Spain. Pina MA; Ara JR; Lasierra P; Modrego PJ; Larrad L Neuroepidemiology; 1999; 18(4):203-9. PubMed ID: 10364721 [TBL] [Abstract][Full Text] [Related]
43. HLA and susceptibility to multiple sclerosis. Clerget-Darpoux F; Govaerts A; Feingold N Tissue Antigens; 1984 Sep; 24(3):160-9. PubMed ID: 6515632 [TBL] [Abstract][Full Text] [Related]
44. Multiple Sclerosis in Keralite siblings after migration to the Middle East: a report of familial Multiple Sclerosis from India. Narayan SK; Kumar S; Prabhakar P; Elangovan S; Baumann N; Verma IC J Neurol Sci; 2007 Sep; 260(1-2):244-8. PubMed ID: 17588606 [TBL] [Abstract][Full Text] [Related]
46. Capturing SNP Association across the NK Receptor and HLA Gene Regions in Multiple Sclerosis by Targeted Penalised Regression Models. Burnard SM; Lea RA; Benton M; Eccles D; Kennedy DW; Lechner-Scott J; Scott RJ Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052430 [TBL] [Abstract][Full Text] [Related]
47. [Immunogenetics of multiple sclerosis]. Clanet M; Cambon-Thomsen A; Rascol A Pathol Biol (Paris); 1987 Mar; 35(3):299-302. PubMed ID: 3295695 [TBL] [Abstract][Full Text] [Related]
48. The Involvement of HLA Class II Alleles in Multiple Sclerosis: A Systematic Review with Meta-analysis. De Silvestri A; Capittini C; Mallucci G; Bergamaschi R; Rebuffi C; Pasi A; Martinetti M; Tinelli C Dis Markers; 2019; 2019():1409069. PubMed ID: 31781296 [TBL] [Abstract][Full Text] [Related]
49. Genetics in multiple sclerosis: past and future perspectives. Harbo HF; Spurkland A Acta Neurol Scand Suppl; 2007; 187():34-8. PubMed ID: 17419826 [TBL] [Abstract][Full Text] [Related]
50. Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study. Kheradvar A; Tabassi AR; Nikbin B; Khosravi F; Naroueynejad M; Moradi B; Amirzargar AA Mult Scler; 2004 Oct; 10(5):526-31. PubMed ID: 15471368 [TBL] [Abstract][Full Text] [Related]
51. Multiple sclerosis: doubling down on MHC. Martin R; Sospedra M; Eiermann T; Olsson T Trends Genet; 2021 Sep; 37(9):784-797. PubMed ID: 34006391 [TBL] [Abstract][Full Text] [Related]
52. Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12. Vitale E; Cook S; Sun R; Specchia C; Subramanian K; Rocchi M; Nathanson D; Schwalb M; Devoto M; Rohowsky-Kochan C Hum Mol Genet; 2002 Feb; 11(3):295-300. PubMed ID: 11823448 [TBL] [Abstract][Full Text] [Related]
58. Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand. Miller DH; Hornabrook RW; Dagger J; Fong R J Neurol Neurosurg Psychiatry; 1986 Jan; 49(1):43-6. PubMed ID: 3457100 [TBL] [Abstract][Full Text] [Related]